Lv1
50 积分 2021-05-31 加入
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
12天前
已完结
Pan-cancer human brain metastases atlas at single-cell resolution
13天前
已完结
NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China
3个月前
已完结
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
4个月前
已完结
Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells
4个月前
已完结
Tumour heterogeneity and resistance to cancer therapies
4个月前
已完结
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
5个月前
已完结
Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer
6个月前
已完结
Glioma 2024版
8个月前
已完结
Glioma
8个月前
已关闭
皖公网安备34019202002308
